CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on creating new nanomedicines that target Tumour-Associated Macrophages (TAM) to enhance anti-tumour immune responses. By re-educating or eliminating TAM, the project aims to improve cancer treatment outcomes.
This project is focused on the development of novel nanomedicines effective in targeting the immunosuppressive, pro-tumoural, Tumour-Associated Macrophages (TAM) with the aim to manipulate the host’s immune system and improve anti-tumour responses.
In most patients, chronic inflammation and immune suppression are the dominant effects in the tumour microenvironment.
The infiltration of TAM in tumour tissues has been shown to support tumour growth, invasion and metastasis.
Indeed, high density of…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
